After Running Lilly From China, CEO Says Local Commitment, Innovation Remain Priorities
This article was originally published in PharmAsia News
Executive Summary
For almost the entire month of March, Eli Lilly & Co. CEO John Lechleiter ran his company from China, a feat that included hosting Lilly's annual global leadership summit in Shanghai, where 150 high-level Lilly execs gathered to get a firsthand look at the country, visiting hospitals and research centers and meeting with government officials